6533b82ffe1ef96bd1295113

RESEARCH PRODUCT

Perioperative and Periprocedural Management of Antithrombotic Therapy: Consensus Document of SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVEI, SECOT and AEU

Raquel OlivaEnrique Santos-buesoFrancisco HidalgoPilar SierraInmaculada RoldánElena FigueroVanessa RoldánR. FerrandisJuan V. LlauLuis LeyJosé Mateo ArranzJosé María LobosJuan José Gómez-doblasJuan I. ArcelusAna GómezDavid VivasDavid VivasAinhoa SerranoAndres IñiguezConcepción CassinelloIsabel EgocheagaAntonio BujaldónJosé Luis FerreiroFrancisco LeyvaFernando AlbercaFuat ArikanAdrián GuerreroPascual Marco VeraVicente PalomoManuel AnguitaAntonio Tello-montoliuFrancisco MarínJuan M. Ruiz-nodarJuan Francisco HermidaRafael MuñozMaría José Ramos-galloRafael OteroJosé A. UrbanoA. Gómez-luqueJosé Luis LlisterriCarmen MonteroOlga MadridanoAlfonso Martín

subject

Malemedicine.medical_specialtymedicine.drug_classHemorrhage030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciences0302 clinical medicineFibrinolytic AgentsRisk FactorsThromboembolismIntervention (counseling)Preoperative CareAntithromboticmedicineHumans030212 general & internal medicineIntensive care medicineAgedAged 80 and overThrombotic riskIntraoperative CareDrug Substitutionbusiness.industryAnticoagulantAnticoagulantsGeneral MedicinePerioperativemedicine.diseaseThrombosisDiscontinuationConventional PCIFemaleAntiagregación Anticoagulación Anticoagulation Antiplatelet Antithrombotic Antitrombótico Cirugía SurgerybusinessPlatelet Aggregation Inhibitors

description

During the last few years, the number of patients receiving anticoagulant and antiplatelet therapy has increased worldwide. Since this is a chronic treatment, patients receiving it can be expected to need some kind of surgery or intervention during their lifetime that may require treatment discontinuation. The decision to withdraw antithrombotic therapy depends on the patient's thrombotic risk versus hemorrhagic risk. Assessment of both factors will show the precise management of anticoagulant and antiplatelet therapy in these scenarios. The aim of this consensus document, coordinated by the Cardiovascular Thrombosis Working Group of the Spanish Society of Cardiology, and endorsed by most of the Spanish scientific societies of clinical specialities that may play a role in the patient-health care process during the perioperative or periprocedural period, is to recommend some simple and practical guidelines with a view to homogenizing daily clinical practice.

yearjournalcountryeditionlanguage
2018-01-01Revista Española de Cardiología (English Edition)
https://doi.org/10.1016/j.rec.2018.01.029